Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SINPHAR AGM Information 2020

Jun 8, 2020

51911_rns_2020-06-08_02f71565-b791-45bd-bf16-0334ff0ed9c9.pdf

AGM Information

Open in viewer

Opens in your device viewer

Meeting Notice

for

Annual Shareholders’ Meeting

(Summary Translation)

The 2020 Annual Shareholders’ Meeting (the “Meeting”) of Sinphar Pharmaceutical Co.,Ltd. (the “Company”) will be convened at 10:00 a.m., Tuesday, May 27, 2020 at Talent Training Center 1st Training Room (located at No.95, Xinliao Rd., Dongshan Township, Yilan County 269, Taiwan (R.O.C.))

  1. The agenda for the Meeting is as follows:

    • I. Report Items (報告事項)

    • (1) Business operations report: 2019

    • ( 一百零八年度營業報告)

    • (2) Supervisor’s review report on the 2019 financial statements

    • ( 監察人審查一百零八年度決算表冊報告 )

    • (3) Distribution of 2019 profit for Employee Remuneration and Directors' and Supervisors' Remunerations

      • ( 民國一百零八年度員工及董監酬勞分派情形報告 )
    • (4) Others operations report

      • ( 其他報告事項 )

II. Items for Approval ( 承認事項 )

  • (1) Business operational reports and financial statements: 2019

    • ( 一百零八年度營業報告書暨財務報表案 )
  • (2) Proposal for the distribution of 2019 profit

    • ( 一百零八年度盈餘分派案 )

III. Items for Discussion ( 討論事項 )

  • (1) Proposal for distribution of Additional paid-in capital

    • ( 本公司資本公積發放現金案 )
  • (2) Amendment to Articles of Incorporation (Company's Corporate Charter)

    • ( 本公司章程修正案 )
  • (3) Amendment to Operational procedures for Acquisition and

Disposal of Assets

  - ( 本公司取得及處分重要資產程序修正案 ) 
  • (4) Amendment to the Rules of Procedure for Shareholder Meetings

  • ( 本公司股東會議事規則修正案 )

  • (5) Amendment to the Rules for Director and Supervisor Elections

    • ( 本公司董事及監察人選舉辦法修正案 )
  1. The proposal for adoption of distribution of d istribution adopted at the meeting of the Board of Directors is as follows:

    • The Board of Directors has proposed to Additional paid-in capital to be distributed with NT$ 0.2 per share on the basis of the number of issued and outstanding stocks registered in the Common Stockholders’ Roster as of the date of record.

    • ( 依普通股發行溢價之資本公積提撥,按資本公積發放現金基準日股東 名簿記載各股東及其持有股數計算,每股發放現金新台幣約 0.2 元 )

Board of Directors

Sinphar Pharmaceutical Co., Ltd.